Novan's (NOVN - Get Report) stock is trading at nearly double last month's $11 IPO price and with a pair of Phase III trials coming up for its dermatological drug, CEO Nate Stasko says the company is merely piercing the skin of its long-term potential. Stasko estimated between 40 and 50 million Americans suffer from acne vulgaris and can be helped by his nitric oxide-based treatment. Nitric oxide is made in the skin by almost every cell type. It has a natural role in barrier repair, wound healing, host defense against invading microbes, and as a modulator of inflammatory processes. But in many chronic inflammatory skin diseases and in skin infections, the body's systems fail and require a boost of nitric oxide to 'reprogram' the system or kill bacteria, viruses, or fungi. Novan's two, identically designed Phase 3 pivotal clinical trials will evaluate the efficacy and safety of topical nitric oxide-releasing product candidate SB204 Gel in the treatment of acne vulgaris. These two trials aim to demonstrate the safety and efficacy of SB204 in over 2600 patients with acne vulgaris.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
3 SUVs That Could Revolutionize Your Carpool in 2020
Mercedes, Kia, and Subaru all showed off all-new SUVs at the 2019 New York Auto Show that could add comfort and style to your daily commute.
Amazon, Boeing, Lam Research: Three Earnings Reports to Watch This Week
Feeling overwhelmed by the earnings avalanche? Jeff Marks, Senior Analyst for Action Alerts Plus, zeros in on three earnings that Jim Cramer's members-only investing club is keeping its eye on this week.
Why Crude Is on the Rise and What it Could Mean for the Oil Market
Crude oil prices jumped more than 2 percent to more than $65 per barrel for the first time since November 2018. Here's what investors need to keep in mind now.
One Major Takeaway from Halliburton's Earnings Report Investors Need to Know
Following Halliburton's revenue beat, Jeff Marks, senior analyst for ActionAlertsPlus, thinks the worst may be behind the energy provider.
How to Retire In Your Thirties, FIRE Pros and Cons
Maybe millennials are onto something, the FIRE movement explained. Watch the video for an excerpt of TheStreet event Retirement, Taxes & Income Strategies Symposium.